GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Ampio Pharmaceuticals Inc (AMPE) [hlAlert]

Ampio Pharmaceuticals, Inc. (Ampio Pharmaceuticals), formerly Chay Enterprises, Inc., develops drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The Company's product pipeline includes new uses for approved drugs and new molecular entities (NMEs) for therapeutic areas, including metabolic
disease, eye disease, kidney disease, inflammation and central nervous system (CNS) disease. Ampio Pharmaceuticals' pipeline focuses on drugs with the potential to be safe and effective for human use. Optina is an oral drug being developed as a new treatment for diabetic retinopathy and diabetic macular edema. Vasaloc is being developed as an existing oral drug that will be a new treatment for diabetic nephropathy. In March 2010, the Company announced that it has merged with DMI Life Sciences, Inc to form Ampio Pharmaceuticals, Inc.
.
( Total: 1 Current Stock Recommendations )
Ampio Pharmaceuticals Inc   (1)
Buy 100%
Related companies
Show  

Date (ET)MemberRatingYTD
Gains
 
3/17/2014  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy